Stay updated on Adagrasib + BI 1701963 in Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.

Latest updates to the Adagrasib + BI 1701963 in Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference12%

- Check30 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a v3.1.0 release tag is now in effect.SummaryDifference0.3%

- Check44 days agoChange DetectedVersion upgraded from v3.0.1 to v3.0.2; 'Back to Top' link removed.SummaryDifference0.7%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%

- Check58 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference11%

- Check73 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to Adagrasib + BI 1701963 in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.